Cargando…
Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis
INTRODUCTION: In immune-mediated inflammatory diseases, there is a lack of -estimates of glucocorticoid dose–response diabetes risk that consider changes in prescribed dose over time and disease activity. RESEARCH DESIGN AND METHODS: Population-based longitudinal analysis of electronic health record...
Autores principales: | Wu, Jianhua, Mackie, Sarah L, Pujades-Rodriguez, Mar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389515/ https://www.ncbi.nlm.nih.gov/pubmed/32719077 http://dx.doi.org/10.1136/bmjdrc-2020-001220 |
Ejemplares similares
-
Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2020) -
Dose-Dependent Effect of Rosuvastatin on VLDL–Apolipoprotein C-III Kinetics in the Metabolic Syndrome
por: Ooi, Esther M.M., et al.
Publicado: (2008) -
Associations between social network properties and metabolic syndrome and the mediating effect of physical activity: findings from the Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) Cohort
por: Kim, Kwanghyun, et al.
Publicado: (2020) -
Objectively assessed physical activity, adiposity, and inflammatory markers in people with type 2 diabetes
por: Hamer, Mark, et al.
Publicado: (2014) -
Impaired Succinate Response to a Mixed Meal in Obesity and Type 2 Diabetes Is Normalized After Metabolic Surgery
por: Astiarraga, Brenno, et al.
Publicado: (2020)